2022 U.S. Virtual Magic Wand® (VMW) Participants

Allison Robbins, MD

Allison Robbins, MD
Brown University | Rhode Island Hospital

Allison Robbins, MD, is a dermatology resident at Brown University/Rhode Island Hospital. She grew up in North Bennington, VT and obtained a Bachelor of Arts in Biological Sciences from Wellesley College where she also was a collegiate field hockey and lacrosse athlete. After graduating college she worked as a clinical research coordinator in a multiple sclerosis laboratory at Brigham and Women’s Hospital in Boston, MA. She returned to her home state to attend medical school at the Robert Larner, MD College of Medicine at the University of Vermont followed by a preliminary medicine intern year at Mount Auburn Hospital in Cambridge, MA. She has specific interests in population based preventive healthcare in rural settings and procedural dermatology. Outside of work she enjoys hiking, biking, running, skiing, cooking, gardening, traveling, and spending time with family and friends.


Andrew Park, MD, MBA

Andrew Park, MD, MBA
University of Texas Southwestern Medical Center

Andrew Park, MD, MBA is currently a dermatology resident at the University of Texas Southwestern Medical Center. He is a graduate of the dual MD-MBA Program at Dartmouth, having received his degrees from the Geisel School of Medicine and the Tuck School of Business. His interests are in the clinical applications of artificial intelligence, data science policy, and healthcare technology design. Prior to his interest in data science, Andrew’s work focused on elucidating innate and adaptive immune pathways to Cutibacterium acnes and Mycobacterium leprae at UCLA and Bellevue Hospital, respectively. He grew up in five countries, works as a freelance journalist and graphic designer, and enjoys snowboarding.


Arlene Ruiz de Luzuriaga, MD, MPH, MBA

Arlene Ruiz de Luzuriaga, MD, MPH, MBA
University of Chicago

Arlene Ruiz de Luzuriaga is an Assistant Professor of Medicine in the Section of Dermatology, and Vice-Chief for Dermatopathology Operations at the University of Chicago. She is a graduate of the Duke University School of Medicine. Dr. Ruiz de Luzuriaga also holds an MPH from the University of North Carolina at Chapel Hill and an MBA with honors from the University of Chicago, where she received the Vashee Promising Entrepreneur Award from the Polsky Center for Entrepreneurship and Innovation in 2017.

She completed her dermatology residency at the University of Chicago, serving as Chief Resident in her final year of residency, and also completed her dermatopathology fellowship. She has also worked as an Associate Staff at the Cleveland Clinic, as well as in a private practice in the southern suburbs of Chicago. Dr. Ruiz de Luzuriaga has recently been a venture fellow for the International Cancer Impact Fund, and has served as a coach for the I-Corps Program and a judge for the College New Venture Program at the University of Chicago. Dr. Ruiz de Luzuriaga is interested in epidemiologic studies in dermatology and dermatopathology, clinical informatics, and the use of information technology for the improvement of patient care, diagnosis and treatment algorithms, quality improvement, and medical education. Her clinical focus is on total body photography, dermatoscopy, skin cancer surveillance, and melanoma prevention and early detection. Through the VMW Program Dr. Ruiz de Luzuriaga hopes to learn more about problem framing and innovation strategies that will be essential to advancing the way we care for dermatologic disease.


Colleen Cotton, MD

Colleen Cotton, MD
Medical University of South Carolina

Dr. Colleen Cotton is an Assistant Professor of pediatric dermatology at the Medical University of South Carolina. She is board-certified in dermatology and pediatric dermatology. She completed a clinical research fellowship in pediatric dermatology at the University of California, San Diego before starting her dermatology residency at the University of Arizona. She concluded her training with a pediatric dermatology fellowship at the Children’s Hospital of Philadelphia. She is one of only two fellowship-trained, board-certified pediatric dermatologists in the state of South Carolina. Her particular clinical interests include hidradenitis suppurativa, hemangiomas, and vascular anomalies. Dr. Cotton is also an active member on committees for the American Academy of Dermatology, Society for Pediatric Dermatology, and the Pediatric Dermatology Research Alliance. She participates in both investigator-initiated and industry-sponsored clinical trials for adult and pediatric dermatologic diseases.


Daniel Schlessinger, MD

Daniel Schlessinger, MD
Medical University of South Carolina

Daniel Schlessinger, MD is a rising second-year dermatology resident at Washington University in St. Louis with interests in innovation, dermatologic surgery, and artificial intelligence in dermatology. Born and raised in Omaha, Nebraska, he co-invented a 1% hydrocortisone balm, FixMySkin, at the age of 12 and patented, developed, and marketed it throughout middle and high school. He completed his undergraduate and medical school studies at Northwestern University as part of the Honors Program in Medical Education, graduating with Honors in Classics. He researched throughout undergraduate and medical school with Dr. Murad Alam, focusing on the development of core outcome sets for the improvement of clinical trials in dermatology. He completed a preliminary-medicine intern year at Massachusetts General Hospital. During residency, he has continued research in medical education in dermatologic surgery and has helped create educational content for his residency program's Twitter account (@WashUDerm). He is interested in applying artificial intelligence to complex and unusual problems in dermatology. In his free time, he enjoys exploring St. Louis with his fiancée, Stephanie, and their puppy, Mischief; practicing yoga; and playing trivia.


David G. Li, MD, MBA

David G. Li, MD, MBA
Harvard Combined Dermatology Residency Training Program

David G. Li, MD, MBA is a dermatology resident at the Harvard Combined Dermatology Residency Training Program in Boston, MA. His academic interests include general and medical dermatology as well as entrepreneurial engagements aimed at impacting patient care on a large scale. His previous experience in health care innovation includes serving as a co-founder and advisor for Lucid Dermatology, Inc.

Prior to starting residency, David completed joint MD and MBA degrees through Tufts University School of Medicine and Brandeis University, where he was active in pharma/biotech consulting and placed nationally in multiple case competitions. During this time, he also served as an operations consultant for the clinical trials division at Tufts Medical Center. After his clinical clerkships, he completed a one-year predoctoral NIH fellowship under Dr. Arash Mostaghimi with a research emphasis on non-invasive modalities (e.g. thermal imaging) to better diagnose skin infections.

In his spare time, David is an avid learner and loves to read on topics across various disciplines outside the scope of medicine. In addition, he is a food/drink enthusiast and enjoys cooking for his friends. He also loves dogs and is the dog dad to a female Australian shepherd named Laika.


Dawn Eichenfield, MD, PhD

Dawn Eichenfield, MD, PhD
Rady Children’s Hospital-San Diego | UC San Diego School of Medicine

Dawn Eichenfield, MD, PhD is a dermatologist at Rady Children’s Hospital-San Diego and an Assistant Clinical Professor of Dermatology at UC San Diego School of Medicine.

Dr. Eichenfield graduated from the Massachusetts Institute of Technology where she studied Biology and Psychology, and conducted both Immunology and Bioengineering research. Before joining the UCSD Department of Dermatology, she completed a successful combined MD and PhD training program at UCSD. During her residency, Dr. Eichenfield served as Chief Resident and went on to complete her fellowship in pediatric dermatology at Rady Children’s Hospital.

As a resident and fellow, Dr. Eichenfield has continued to help advance translational and basic research by undertaking studies to better understand the genetic basis of dermatologic conditions. Dr. Eichenfield is especially passionate about pediatric dermatologic diseases, as well as the implementation of new treatment approaches for these diseases. She hopes that the Magic Wand Program who give her the tools to develop personalized solutions to offer her patients.


Elena Pope, MD, MSc, FRCPC

Elena Pope, MD, MSc, FRCPC
University of Toronto | Hospital for Sick Children, Toronto

Dr. Elena Pope is a Professor in the Department of Paediatrics at the University of Toronto.  In 2003, she became the Director of the Section of Pediatric Dermatology, Division of Paediatric Medicine at the Hospital for Sick Children, Toronto, Ontario, Canada.

She received her medical training at The Institute of Medicine and Pharmacy, Bucharest Romania and the University of Toronto, and completed her training in Paediatrics and a fellowship in Pediatric Dermatology at the Hospital for Sick Children, Toronto.  She has a graduate degree in Clinical Pharmacology, University of Toronto and a Diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine, University of London, UK.

Since becoming Director of Paediatric Dermatology, Dr. Pope has instituted innovative approaches to the care of paediatric dermatological conditions by establishing interdisciplinary clinics in Epidermolysis Bullosa, Cutaneous T-cell lymphoma, Vascular Tumor Clinic, Morphea and Genodermatoses.

She is a Project Investigator at the SickKids Research Institute and is involved in numerous investigator-initiated research projects stemming from her clinical interests and focused on new interventions for rare and common pediatric dermatology conditions.  She is the inventor of the iscorEB, an outcome tool designed to assess severity of patients with epidermolysis bullosa.

Dr. Pope has many teaching commitments at the Hospital for Sick Children and has been the recipient of several teaching and mentorship awards from SPD and AAD.

Dr. Pope has held leadership positions in PeDRA (Pediatric Dermatology Research Alliance)- past chair of the grants committee and communication committee and ex-member of the PeDRA’s Executive Committee and Board of Directors.


Eric Yang, MD

Eric Yang, MD
Brown University

Eric Yang is a dermatology resident physician at Brown University. He received his undergraduate degree in Biochemistry & Cell Biology from the University of California, San Diego, then received his medical degree from Chicago Medical School at Rosalind Franklin University. He has a background in software, developing mobile and web applications to improve electronic medical record interoperability and serving as a systems integration engineer at Illumina to launch the novel NextSeq desktop genomic sequencer. His interests include general dermatology, healthcare policy, healthcare costs, and medical devices.


Ian Ferguson, MD

Ian Ferguson, MD
Washington University

Ian Ferguson, MD is a dermatology resident at Washington University in St. Louis with an interest in cutaneous oncology. He earned his medical degree at Washington University in St. Louis, along with a master’s degree in biomedical sciences studying cancer genetics. He graduated as a member of Alpha Omega Alpha and the Gold Humanism Honor Society. He completed his internship at Brigham and Women’s Hospital working closely with clinicians from the Dana Farber Cancer Institute. Prior to pursuing a career in medicine, Ian worked in business development for a legal technology start-up. He is interested in promoting disruptive innovation in healthcare to advance cancer diagnostics and therapeutics.


John S. Barbieri, MD, MBA

John S. Barbieri, MD, MBA
Brigham and Women’s Hospital

John S. Barbieri, MD, MBA, is an Instructor in the Department of Dermatology at the Brigham and Women’s Hospital, where he serves as Director of the Advanced Acne Therapeutics Clinic. His research interests include acne, patient-reported outcomes, antibiotic stewardship, and health services research. His work has been published in high-impact dermatology journals such as JAMA Dermatology, Journal of the American Academy of Dermatology, and British Journal of Dermatology and he has over 90 peer-reviewed publications. He has been invited to speak at regional, national, and international conferences on the management of acne. He is the incoming Chair of the American Academy of Dermatology Drug Pricing and Transparency Task Force and is a member of the International Dermatology Outcome Measures Acne Work Group, which is a non-profit organization seeking to develop and validate outcome measures throughout dermatology. He has completed the Journal of the American Academy of Dermatology Editorial Mentorship Program and frequently serves as a peer reviewer for major journals such as JAMA Dermatology, the Journal of the American Academy of Dermatology, the British Journal of Dermatology, and the Journal of Investigative Dermatology.


Julia Arzeno, MD

Julia Arzeno, MD
University of California, Los Angeles

Julia Arzeno, MD earned her medical degree from UCLA in 2017 and was inducted into the Alpha Omega Alpha honor society. She continued on at UCLA as a resident in dermatology, where she is currently serving as Chief Resident during her final year. She has a strong interest in cutaneous oncology and will be starting a Micrographic Surgery and Dermatologic Oncology fellowship following residency. Julia is passionate about research and innovation and has participated in multiple NIH-funded research programs at UCSF and Stanford. She has published multiple articles in peer-reviewed journals, authored several book chapters, and presented at national conferences. She has continued to do research throughout residency, most recently focusing on the effect of dermatologic procedures on wound healing and aging biomarkers. As a resident, she also served as the coordinator for Venice Family Dermatology Clinic, which provides dermatologic care to people in need. She aims to leverage her medical knowledge and research background to develop innovations that will improve patient health and quality of life. 


Katharina S. Shaw, MD

Katharina S. Shaw, MD
New York University

Katharina S. Shaw, MD is a rising third year dermatology resident at New York University with a strong interest in rheumatologic dermatology, hair and nail disorders and dermatology education. She completed her undergraduate and medical school studies at Columbia University and her intern year at Memorial Sloan Kettering Cancer Center. During residency, she has been an avid participant and contributor to her institution's Hair Research Group and was recently awarded a prestigious educational grant from Pfizer Global Medical Grants (GMG) to create a novel, three-tiered online educational system that optimizes provider and patient comprehension of emerging treatments for alopecia areata. During her final year of residency, she will serve as Academic Chief Resident for the NYU Dermatology Residency Program, reflecting her commitment to medical education. She looks forward to completing a yearlong fellowship in rheumatologic dermatology at Brigham & Women's Hospital after residency and channel her passion for research and innovation towards improving outcomes in patients with autoimmune connective tissue disease. 


Kevin Patel, MD

Kevin Patel, MD
The University of Texas at Austin

Kevin Patel, MD is a rising second year dermatology resident at The University of Texas at Austin who grew up in the western suburbs of Chicago. He completed his undergraduate studies at the University of Illinois at Urbana-Champaign where he majored in molecular biology and psychology. Outside of classes, he served as a research director for BioAnalytics, a startup company focused on understanding saccadic eye movements in collegiate athletes. He then received his medical degree from Rosalind Franklin University, during which he also participated as a visiting research fellow at Northwestern University under the guidance of Dr. Jonathan Silverberg and Dr. Amy Paller. His research efforts not only led to over 30 peer-reviewed publications in high tier journals, but also piqued his interest in analyzing large scale national datasets to understand the mental health association and cost of chronic skin diseases. He then completed his internship in preliminary medicine at the Massachusetts General Hospital where he continued to strengthen his skillset in data analysis. During residency, Kevin has geared his attention towards drug vehicle development. He has a passion for research and innovation and hopes through these measures he can improve patient outcomes and disease burden.


Laura Gardner, MD

Laura Gardner, MD
Vanderbilt University

Dr. Gardner is a Utah native, completing her B.S. in biochemistry at Utah State University and her M.D. at the University of Utah School of Medicine where she was active in Gold Humanism Honor Society, American Medical Women’s Association, and the Sex & Gender Health Education Summit—a collaboration geared to integrate sex and gender-based evidence into health profession curricula. The strong culture of innovation at the University of Utah School of Medicine inspired her to pursue an M.S. in bioengineering with an emphasis on problem-based innovation and healthcare technology development. She led her engineering team to develop and apply for patents on a novel videoscopic vaginal speculum and develop a standardized cervical cancer detection kit that respectively won runner up and global health awards at medical technology competitions. She completed her internship at Providence Health in Spokane, Washington before moving to Nashville, TN where she is currently a dermatology resident at Vanderbilt University Medical Center. She has lectured to her department on the importance of physicians as innovators and on identifying clinical problems.

She has keen interest in getting to the heart of clinical problems through needs finding and ensuring that treatments and technologies are appropriately designed to provide thoughtful, durable solutions. She has a vision for developing elegantly designed treatments for patients, with special interests in pediatric and women’s health. Her clinical interests include dermatopathology, pigmented lesions, pediatrics, and rare and inherited skin disease. She also has interests in free open-access medicine. Outside of work she enjoys baking botanically inspired cakes, stand-up paddle board, volleyball, and playing her piano.


Morgan Murphrey, MD

Morgan Murphrey, MD
University of California, Davis

Morgan Murphrey is a rising PGY-3 dermatology resident at UC Davis in Sacramento, CA. She completed her undergraduate education at California Polytechnic State University in San Luis Obispo, where she graduated summa cum laude with a degree in Biochemistry and a minor in Psychology. She first became interested in research and innovation while there and helped synthesize an inorganic ruthenium ligand, which serves as a probe for in vivo reactive oxygen species production. She went on to complete medical school at Creighton University, where she concurrently earned her medical degree and Master's degree in Health Care Ethics. Between her third and fourth year of medical school, she solidified her passion for research and innovation while completing a pre-doctoral research fellowship at Northwestern University with Dr. Amy Paller, where she participated in both industry and investigator-initiated clinical trials. She is passionate about finding innovative solutions to problems in dermatology. She has a particular interest in implicit bias and health care ethics within dermatology.


Nicole Gunasekera, MD, MBA

Nicole Gunasekera, MD, MBA
Harvard Combined Dermatology Training Program

Nicole Gunasekera, MD, MBA is a Chief Resident in the Harvard Combined Dermatology Training Program who is passionate about clinical service innovation, access to care, and equity in dermatology. She completed her undergraduate studies at Vanderbilt University where she majored in Public Health & Health Disparities. After graduation, she worked as an Associate Consultant at Bain & Company, where she confirmed both her passion for addressing high impact challenges and her interest in the healthcare field. She completed the combined MD/MBA program at Harvard Medical School and Harvard Business School. During dermatology residency, her research has focused on understanding appointment non-attendance and developing innovative strategies to improve appointment utilization in outpatient dermatology. In the fall of 2021, she will be starting as faculty in the Department of Dermatology at Brigham & Women’s Hospital, where she will serve as Assistant Director of Clinical Business Operations, Director of the Vitiligo Clinic, and Co-Director of the Skin of Color Clinic.


Nikolai Klebanov, MD

Nikolai Klebanov, MD
Harvard Combined Dermatology Training Program

Nikolai Klebanov MD is a rising second year dermatology resident at the Harvard Combined Dermatology Residency Program with a strong interest in technology and informatics. He completed his undergraduate degree in chemical engineering and medical school studies at Tufts University as part of the prestigious Early Assurance program. During medical school he worked at a healthcare startup focusing on building a machine-learning driven diagnostic engine. He built upon his interests during a yearlong research fellowship at Massachusetts General Hospital, aimed at using computational methods to study the role of genetic mutations in the development of benign and malignant skin lesions as well as in regulating anti-tumor immunity. He completed an intern year at Brockton Hospital, where he continued his studies focused on gene expression as a predictor of oncologic safety of biologic therapies. During residency, he contributed to ongoing coronavirus pandemic efforts by investigating how exposure to commonly used immunomodulatory systemic medications affects COVID-19 risk. He has a passion for research and the use of computational methods and machine learning in medicine, and through these avenues he hopes to modernize and streamline healthcare delivery.


Sally Tan, MD, MPH

Sally Tan, MD, MPH
University of California, San Francisco

Sally Tan, MD, MPH is passionate about advancing the development of novel targeted therapeutics within dermatology and using telehealth to improve care access and diversity of patients enrolled in clinical trials. She completed her undergraduate studies at Yale University, where she double majored in molecular biology and economics, and also earned a dual Master of Science degree in immunology. She subsequently joined McKinsey & Company as a management consultant, advising biopharmaceutical companies on pipeline asset prioritization and operational efficiency of their clinical development programs. Dr. Tan earned her MD with cum laude honors from Harvard Medical School, where she also completed an MPH in biostatistics and clinical trial design. Currently, she is a dermatology resident at UCSF.


Spyros Siscos, MD

Spyros Siscos, MD
University of Kansas Medical Center

Spyros Siscos, MD is a rising third-year chief dermatology resident at the University of Kansas Medical Center with a strong interest in Mohs micrographic surgery and cutaneous oncology. He graduated from the University of Kansas School of Medicine at the top of his class and was inducted into the Alpha Omega Alpha and Gold Humanism Honor Societies. He has published several articles and a textbook chapter on various topics within the field of Mohs surgery. He is particularly interested in expanding the utilization of Mohs surgery to treat melanoma. Other interests include laser and cosmetic surgery, scar revision, medical innovation and entrepreneurship.


Sungat Grewal, MD

Sungat Grewal, MD
University of California, San Francisco

Sungat K. Grewal is a current PGY-4 in the Department of Dermatology at the University of California, San Francisco (UCSF), and incoming Micrographic Surgery and Dermatologic Oncology/Procedural Dermatology fellow at the University of California, Irvine (UCI). Originally from San Jose, CA, she attended the University of California, Los Angeles (UCLA) where she earned her Bachelor of Sciences. At the Geisinger School of Medicine (GCSoM), Sungat was inducted into both the Alpha Omega Alpha (AOA) and Gold Humanism Honor (GHHS) societies. During her third year, she was awarded the NIH Ruth L. Kirchstein National Research Service Award to pursue a pre-doctoral fellowship in Dermato-epidemiology at the University of Pennsylvania (UPenn). Under the mentorship of Dr. Joel Gelfand MD MSCE FAAD, she investigated the epidemiology of psoriasis, its comorbidities, and therapeutic implications. As an intern at the Brigham (BWH), Sungat continued to establish a rigorous foundation to thrive in what she envisioned to be a career in complex medical dermatology. At UCSF, she was surprised by the immense joy she experienced during her surgical rotations. As she took deeper interest in procedural dermatology, she began to appreciate practice gaps as they relate to skin of color. As a member of the Diversity, Equity, and Inclusion (DEI) Committee, she supported efforts to incorporate DEI objectives into each lecture, prompting lecturers to show disease processes in diverse patients, and dissect clinical trials by demographics to question their generalizability. She also served as both Curriculum and Cosmetics Chief and went on to receive both the Women’s Dermatologic Society Mentorship Award to learn more about laser and light-based devices under the mentorship of Dr. Arisa Ortiz MD FAAD, as well as the AAD Resident Quality Improvement Award for spearheading the launch of a departmental initiative SamTrak (Reliable Sample Tracking) under the mentorship of Dr. Rita Khodosh MD PhD to minimize loss of pathology specimens at UCSF. Sungat’s long-term goal is to become an academic Mohs surgeon and laser expert, with a specific focus in skin of color because this career path combines her passion for cutaneous oncology, surgery, and health care disparities. She is excited to participate in Harvard's Virtual Magic Wand Initiative, where which she looks forward to strengthening the skills needed to address unmet needs of minoritized patients with a creative, critical and innovative eye.